Facetten
Zugriff
Einrichtung
Medientyp
- Text 6
Karte
Erscheinungsjahr
Autor/in
- Dürig, Jan
- Bertsch, Uta 3
- Mai, Elias K 3
- Goldschmidt, Hartmut 2
- Kunz, Christina 2
- alle zeigen
Sprache
6 Einträge gefunden
-
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
- Goldschmidt, Hartmut
- Mai, Elias K
- Bertsch, Uta
- Fenk, Roland
- Nievergall, Eva
- Tichy, Diana
- Besemer, Britta
-
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
- Dimopoulos, Meletios
- Weisel, Katja
- Moreau, Philippe
- Anderson, Larry D
- White, Darrell
- San-Miguel, Jesus
- Sonneveld, Pieter
-
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
-
-